Connecticut HB 5322: AN ACT CONCERNING A WORKING GROUP REGARDING ENDOMETRIOSIS.
Status: FILE NO. 514 (as of 2026-04-08)
State: Connecticut · Session: 2026 · Bill: HB 5322
Subjects: Diseases, Health care providers, Legislative Department, Legislative Management, Office of, Reports, Women, Children, Seniors, Equity and Opportunity, Commission on
Sponsors: Kathy Kennedy, Eleni Kavros Degraw, Sarah Keitt, Julie Kushner, Antonio Felipe, Martha Marx, Laurie Sweet, Amy Morrin Bello, Lucy Dathan
Bill Text
LCO 1 of 4 General Assembly Substitute Bill No. 5322 February Session, 2026 AN ACT CONCERNING A WORKING GROUP REGARDING ENDOMETRIOSIS. Be it enacted by the Senate and House of Representatives in General Assembly convened: Section 1. (NEW) (Effective from passage) (a) There is established a 1 working group regarding endometriosis for the purpose of evaluating 2 and making recommendations regarding the diagnosis, treatment, 3 research, education and public awareness of endometriosis in the state. 4 The working group shall be within the Legislative Department. The 5 working group shall evaluate the following: 6 (1) The prevalence and impact of endometriosis on residents of the 7 state; 8 (2) Barriers to timely and accurate diagnosis of endometriosis; 9 (3) Access to evidence-based treatment for endometriosis, including, 10 but not limited to, medical, surgical and therapeutic interventions; 11 (4) Insurance coverage and reimbursement practices for the 12 treatment of endometriosis; 13 (5) The impact of endometriosis in the workplace, including, but not 14 limited to, leave, accommodations and employment protections; 15 Substitute Bill No. 5322 LCO 2 of 4 (6) Gaps in public and provider education and training concerning 16 endometriosis; and 17 (7) Opportunities to improve endometriosis data collection, research 18 initiatives and patient outcomes. 19 (b) The working group shall consist of the following members, who 20 shall be appointed not later than thirty days after the effective date of 21 this section: 22 (1) Four appointed by the speaker of the House of Representatives, 23 one of whom shall be a member of the House or Representatives, one of 24 whom shall be a physician licensed pursuant to chapter 370 of the 25 general statutes with demonstrated experience in the diagnosis and 26 treatment of endometriosis, one of whom shall be a representative of a 27 federally qualified health center and one of whom shall be an individual 28 residing in the state who has been diagnosed with endometriosis; 29 (2) Four appointed by the president pro tempore of the Senate, one of 30 whom shall be a member of the Senate, one of whom shall be a physician 31 licensed pursuant to chapter 370 of the general statutes who is a member 32 of the American College of Obstetricians and Gynecologists, one of 33 whom shall be a researcher affiliated with an academic or research 34 institution in the state with expertise in endometriosis and one of whom 35 shall be a patient advocate with experience advocating on behalf of 36 individuals with endometriosis; 37 (3) Four appointed by the minority leader of the House of 38 Representatives, one of whom shall be a member of the House of 39 Representatives, one of whom shall be a pediatric or an adolescent 40 medicine physician licensed pursuant to chapter 370 of the general 41 statutes and currently practicing in the state, one of whom shall be an 42 individual in the state with expertise in racial and health equity or who 43 represents a community-based organization serving historically 44 underserved populations and one of whom shall be a representative of 45 an association of hospitals in the state or an administrator of a hospital 46 in the state; 47 Substitute Bill No. 5322 LCO 3 of 4 (4) Four appointed by the minority leader of the Senate, one of whom 48 shall be a member of the Senate, one of whom shall be a representative 49 of a school-based health center in the state, one of whom shall be a 50 representative of a therapeutic or pharmaceutical manufacturer with 51 experience in treatments related to endometriosis and one of whom 52 shall be an individual residing in the state who has been diagnosed with 53 endometriosis; 54 (5) The Commissioner of Public Health, or the commissioner's 55 designee; 56 (6) The Insurance Commissioner, or the commissioner's designee; 57 and 58 (7) The cochairpersons of the endometriosis data and biorepository 59 program established pursuant to section 10a-132f of the general statutes. 60 (c) Except for members of the General Assembly, members who 61 represent state agencies and the cochairpersons of the endometriosis 62 data and biorepository program, six of the members first appointed 63 shall serve for a term of two years, six of such members shall serve for a 64 term of three years and, thereafter, members shall serve for a term of 65 two years. The executive director of the Commission on Women, 66 Children, Seniors, Equity and Opportunity shall determine which of the 67 members first appointed shall serve for a term of two years and which 68 of such members shall serve for a term of three years. Any vacancy shall 69 be filled by the appointing authority not later than thirty calendar days 70 after the appointment becomes vacant. Any member previously 71 appointed to the working group may be reappointed. The members of 72 the working group shall receive no compensation for their services but 73 may be reimbursed for any necessary expenses in
View Connecticut HB 5322 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.